![](/img/cover-not-exists.png)
O10.04 * THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE
Herrlinger, U., Schafer, N., Steinbach, J. P., Weyerbrock, A., Hau, P., Goldbrunner, R., Leutgeb, B., Urbach, H., Stummer, W., Glas, M.Volume:
16
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nou174.85
Date:
September, 2014
File:
PDF, 30 KB
english, 2014